Search by Drug Name or NDC

    NDC 68382-0786-06 Doxazosin 8 mg/1 Details

    Doxazosin 8 mg/1

    Doxazosin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is DOXAZOSIN MESYLATE.

    Product Information

    NDC 68382-0786
    Product ID 68382-786_92ead971-9de8-4240-b2c7-fc2e9abac7dd
    Associated GPIs 36202005100340
    GCN Sequence Number 015587
    GCN Sequence Number Description doxazosin mesylate TABLET 8 MG ORAL
    HIC3 J7B
    HIC3 Description ALPHA-ADRENERGIC BLOCKING AGENTS
    GCN 33434
    HICL Sequence Number 006031
    HICL Sequence Number Description DOXAZOSIN MESYLATE
    Brand/Generic Generic
    Proprietary Name Doxazosin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Doxazosin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 8
    Active Ingredient Units mg/1
    Substance Name DOXAZOSIN MESYLATE
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208719
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0786-06 (68382078606)

    NDC Package Code 68382-786-06
    Billing NDC 68382078606
    Package 30 TABLET in 1 BOTTLE (68382-786-06)
    Marketing Start Date 2017-08-31
    NDC Exclude Flag N
    Pricing Information N/A